These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 28280138)

  • 41. Population-based risk assessment of APOL1 on renal disease.
    Friedman DJ; Kozlitina J; Genovese G; Jog P; Pollak MR
    J Am Soc Nephrol; 2011 Nov; 22(11):2098-105. PubMed ID: 21997396
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Sickle cell trait: is there an increased VTE risk in pregnancy and the postpartum?
    Pintova S; Cohen HW; Billett HH
    PLoS One; 2013; 8(5):e64141. PubMed ID: 23717554
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Sickle Cell Trait and Kidney Disease in People of African Ancestry With HIV.
    Hung RKY; Binns-Roemer E; Booth JW; Hilton R; Fox J; Burns F; Harber M; Ustianowski A; Hamzah L; Burns JE; Clarke A; Price DA; Kegg S; Onyango D; Santana-Suarez B; Campbell L; Bramham K; Sharpe CC; Sabin CA; Winkler CA; Post FA;
    Kidney Int Rep; 2022 Mar; 7(3):465-473. PubMed ID: 35257059
    [TBL] [Abstract][Full Text] [Related]  

  • 44.
    Doshi MD; Ortigosa-Goggins M; Garg AX; Li L; Poggio ED; Winkler CA; Kopp JB
    J Am Soc Nephrol; 2018 Apr; 29(4):1309-1316. PubMed ID: 29339549
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Association of Sickle Cell Trait with Risk and Mortality of COVID-19: Results from the United Kingdom Biobank.
    Resurreccion WK; Hulsizer J; Shi Z; Wei J; Wang CH; Na R; Zheng SL; Struve C; Helfand BT; Khandekar J; Billings LK; Caplan MS; Xu J
    Am J Trop Med Hyg; 2021 Jun; 105(2):368-371. PubMed ID: 34129519
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Sickle cell trait, APOL1 risk allele status and chronic kidney disease among ART-experienced adults living with HIV in northern Nigeria.
    Abdulhamid A; Shepherd BE; Wudil UJ; Van Wyk C; Dankishiya FS; Hussaini N; Wester CW; Aliyu MH
    Int J STD AIDS; 2024 Jun; ():9564624241262397. PubMed ID: 38915133
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Roles of APOL1 G1 and G2 variants in sickle cell disease patients: kidney is the main target.
    Kormann R; Jannot AS; Narjoz C; Ribeil JA; Manceau S; Delville M; Joste V; Prié D; Pouchot J; Thervet E; Courbebaisse M; Arlet JB
    Br J Haematol; 2017 Oct; 179(2):323-335. PubMed ID: 28699644
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Sickle cell trait and development of microvascular complications in diabetes mellitus.
    Bleyer AJ; Reddy SV; Sujata L; Russell GB; Akinnifesi D; Bleyer AJ; Hire D; Shihabi Z; Knovich MA; Daeihagh P; Calles J; Freedman BI
    Clin J Am Soc Nephrol; 2010 Jun; 5(6):1015-20. PubMed ID: 20299376
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Revisiting racial differences in ESRD due to ADPKD in the United States.
    Murphy EL; Dai F; Blount KL; Droher ML; Liberti L; Crews DC; Dahl NK
    BMC Nephrol; 2019 Feb; 20(1):55. PubMed ID: 30764782
    [TBL] [Abstract][Full Text] [Related]  

  • 50. APOL1 allelic variants are associated with lower age of dialysis initiation and thereby increased dialysis vintage in African and Hispanic Americans with non-diabetic end-stage kidney disease.
    Tzur S; Rosset S; Skorecki K; Wasser WG
    Nephrol Dial Transplant; 2012 Apr; 27(4):1498-505. PubMed ID: 22357707
    [TBL] [Abstract][Full Text] [Related]  

  • 51. APOL1 Genotype, Kidney and Cardiovascular Disease, and Death in Older Adults.
    Mukamal KJ; Tremaglio J; Friedman DJ; Ix JH; Kuller LH; Tracy RP; Pollak MR
    Arterioscler Thromb Vasc Biol; 2016 Feb; 36(2):398-403. PubMed ID: 26634651
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Genetic variants and cell-free hemoglobin processing in sickle cell nephropathy.
    Saraf SL; Zhang X; Shah B; Kanias T; Gudehithlu KP; Kittles R; Machado RF; Arruda JA; Gladwin MT; Singh AK; Gordeuk VR
    Haematologica; 2015 Oct; 100(10):1275-84. PubMed ID: 26206798
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Clinical Genetic Testing for APOL1: Are we There Yet?
    Young BA; Fullerton SM; Wilson JG; Cavanaugh K; Blacksher E; Spigner C; Himmelfarb J; Burke W
    Semin Nephrol; 2017 Nov; 37(6):552-557. PubMed ID: 29110763
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Incident atrial fibrillation and risk of end-stage renal disease in adults with chronic kidney disease.
    Bansal N; Fan D; Hsu CY; Ordonez JD; Marcus GM; Go AS
    Circulation; 2013 Feb; 127(5):569-74. PubMed ID: 23275377
    [TBL] [Abstract][Full Text] [Related]  

  • 55. An African perspective on the genetic risk of chronic kidney disease: a systematic review.
    George C; Yako YY; Okpechi IG; Matsha TE; Kaze Folefack FJ; Kengne AP
    BMC Med Genet; 2018 Oct; 19(1):187. PubMed ID: 30340464
    [TBL] [Abstract][Full Text] [Related]  

  • 56.
    Masimango MI; Jadoul M; Binns-Roemer EA; David VA; Sumaili EK; Winkler CA; Limou S
    Kidney Int Rep; 2022 Mar; 7(3):474-482. PubMed ID: 35257060
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Plasma apolipoprotein L1 levels do not correlate with CKD.
    Bruggeman LA; O'Toole JF; Ross MD; Madhavan SM; Smurzynski M; Wu K; Bosch RJ; Gupta S; Pollak MR; Sedor JR; Kalayjian RC
    J Am Soc Nephrol; 2014 Mar; 25(3):634-44. PubMed ID: 24231663
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Association of sickle cell trait with atrial fibrillation: The REGARDS cohort.
    Douce DR; Soliman EZ; Naik R; Hyacinth HI; Cushman M; Winkler CA; Howard G; Lange EM; Lange LA; Irvin MR; Zakai NA
    J Electrocardiol; 2019; 55():1-5. PubMed ID: 31028976
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Risk of end-stage renal disease from chronic kidney disease defined by decreased glomerular filtration rate in type 1 diabetes: A comparison with type 2 diabetes and the effect of metabolic syndrome.
    Lee YB; Han K; Kim B; Jun JE; Lee SE; Ahn J; Kim G; Jin SM; Kim JH
    Diabetes Metab Res Rev; 2019 Nov; 35(8):e3197. PubMed ID: 31222888
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Human apolipoprotein L1 (ApoL1) in cancer and chronic kidney disease.
    Hu CA; Klopfer EI; Ray PE
    FEBS Lett; 2012 Apr; 586(7):947-55. PubMed ID: 22569246
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.